Xue Bai

机构：Shanxi University, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University · ORCID：0000-0003-0170-9305

发表论文 100 篇 · 总被引 1550 次 · h-index 20

代表论文

• Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism (2024 · Journal of Advanced Research · 被引 71)
• Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Population‐Based Cohort Study (2025 · Alimentary Pharmacology & Therapeutics · 被引 22)
• Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) (2025 · Communications Medicine · 被引 14)
• Exploring the potential of cryptochlorogenic acid as a dietary adjuvant for multi-target combined lung cancer treatment (2024 · Phytomedicine · 被引 14)
• Low polarity fraction of Radix Bupleuri alleviates chronic unpredictable mild stress-induced depression in rats through FXR modulating bile acid homeostasis in liver, gut, and brain (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 10)
• Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case report (2024 · Blood Advances · 被引 5)